Treating the endotheliopathy of SARS-CoV-2 infection with plasma: Lessons learned from optimized trauma resuscitation with blood products

Authors

Shibani Pati, Department of Lab Medicine, University of California San Francisco School of Medicine, San Francisco, California, USA.
Erin Fennern, Department of Surgery, Mount Sinai Icahn School of Medicine, New York, New York, USA.
John B. Holcomb, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Mark Barry, Department of Surgery, University of California San Francisco School of Medicine, San Francisco, California, USA.
Alpa Trivedi, Department of Lab Medicine, University of California San Francisco School of Medicine, San Francisco, California, USA.
Joseph Rappold, Maine Medical CenterFollow

Document Type

Article

Publication Date

7-2021

Institution/Department

Trauma & Acute Care Surgery

Journal Title

Transfusion

MeSH Headings

Aged; Blood Coagulation; Blood Component Transfusion; COVID-19 (blood, pathology, therapy); Endothelium (pathology); Female; Humans; Immunization, Passive (methods); Male; Middle Aged; Resuscitation (methods); SARS-CoV-2 (isolation & purification); Wounds and Injuries (blood, pathology, therapy); COVID-19 Serotherapy

First Page

S336

Last Page

S347

Recommended Citation

Pati S, Fennern E, Holcomb JB, et al. Treating the endotheliopathy of SARS-CoV-2 infection with plasma: Lessons learned from optimized trauma resuscitation with blood products. Transfusion. 2021;61 Suppl 1(Suppl 1):S336-S347. doi:10.1111/trf.16452